Failure to Thrive: Clinical Trials

3 trials for Failure to Thrive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 21Terminated 1

Follow Failure to Thrive: new trials by email Literature Review of Failure to Thrive trials Research Report on Failure to Thrive

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial on the Acceptability of Modified Lipid Based Nutrient Supplements Among Malawian Infants
Nutributter, LNS-20gM, LNS-20gNoM - Malnutrition
Phase 1CompletedTampere University192009-04-012009-06-24
r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence Trial
r-hGH liquid (Saizen), r-hGH freeze-dried - Growth Failure, Growth Hormone Deficiency
Phase 1CompletedEMD Serono302008-07-012013-10-23
Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
Increlex - Growth Failure, X-linked Severe Combined Immunodeficiency (XSCID)
Phase 1 / Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)62007-06-012015-07-03

Narrower conditions

Dwarfism, Pituitary (1)  ·  Growth Disorders (1)  ·  Malnutrition (1)  ·  X-Linked Combined Immunodeficiency Diseases (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Bone Diseases (1)  ·  Bone Diseases, Developmental (1)  ·  Bone Diseases, Endocrine (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Dwarfism (1)  ·  Endocrine System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Hypopituitarism (1)  ·  Hypothalamic Diseases (1)  ·  Immune System Diseases (1)

Interventions

Human Growth Hormone (1)  ·  mecasermin (1)

Sponsors

EMD Serono (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Tampere University (1)

Countries

Germany (1)  ·  Malawi (1)  ·  United States (1)

Top investigators

Kenneth Maleta, MBBS, PhD (1)  ·  Michael Lissy, MD (1)  ·  Per Ashorn, MD, PhD (1)  ·  Suk S De Ravin, M.D. (1)

Results publications

PMID 20961422